These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26258407)

  • 1. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
    Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
    PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
    Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
    Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
    Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Wang Y; Sun N; Lu C; Bei Y; Qian R; Hua L
    Int J Oncol; 2017 Jun; 50(6):2191-2199. PubMed ID: 28498393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
    Ayinde O; Wang Z; Griffin M
    Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
    Yao C; Su L; Shan J; Zhu C; Liu L; Liu C; Xu Y; Yang Z; Bian X; Shao J; Li J; Lai M; Shen J; Qian C
    Stem Cells; 2016 Apr; 34(4):820-31. PubMed ID: 26840943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
    Liu Y; Li Y; Hou R; Shu Z
    J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
    Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
    J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
    Hur K
    BMB Rep; 2015 Apr; 48(4):217-22. PubMed ID: 25603797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
    Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
    Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.